N. Jounai

发表

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env.

K. Hamajima, K. Xin, K. Okuda, 2003, Blood.

The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection.

K. Xin, K. Okuda, Yoshitsugu Kojima, 2007, Vaccine.

DNA Vaccine: Does it Target the Double Stranded-DNA Sensing Pathway?

C. Coban, K. Ishii, C. Tang, 2014 .

Innate Immune Signaling By, Genetic Adjuvants For, Dna Vaccination

C. Coban, K. Ishii, T. Aoshi, 2013 .

Blocking of the TLR5 Activation Domain Hampers Protective Potential of Flagellin DNA Vaccine1

K. Ishii, S. Akira, S. Uematsu, 2007, The Journal of Immunology.

Ligand-induced Ordering of the C-terminal Tail Primes STING for Phosphorylation by TBK1

K. Mizuguchi, K. Ishii, Y. Tsuchiya, 2016, EBioMedicine.

Results in Robust CD 8 Extracellular Vesicles via DNA Vaccination CD 63-Mediated Antigen Delivery into Etsushi Kuroda

K. Ishii, E. Moriishi, N. Jounai, 2017 .

Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV

K. Okuda, H. Mizuguchi, T. Hayakawa, 2005, Gene Therapy.

This information is current as Beclin 1 Processes through an Association with NLRP 4 Negatively Regulates Autophagic

K. Ishii, M. Shiina, K. Ogata, 2010 .

Extrachromosomal Histone H2B Mediates Innate Antiviral Immune Responses Induced by Intracellular Double-Stranded DNA

A. Miyawaki, Asako Sakaue-Sawano, K. Ishii, 2009, Journal of Virology.

Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses.

H. Mizukami, K. Ozawa, K. Hamajima, 2002, Human gene therapy.

DNA vaccines

C. Coban, K. Ishii, N. Jounai, 2013, Human vaccines & immunotherapeutics.

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.

K. Hamajima, K. Xin, K. Okuda, 2002, Vaccine.

Chitin Micro-Particles (CMP): a useful adjuvant for inducing viral specific immunity when delivered intranasally with an HIV-DNA vaccine.

K. Matsui, K. Hamajima, K. Xin, 2003, Viral immunology.

The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant

Benoit H. Dessailly, K. Mizuguchi, C. Coban, 2013, PloS one.

Comparison of antigen-specific cellular immune responses between individual PBMCs and splenocytes.

K. Xin, K. Okuda, F. Takeshita, 2005, Vaccine.

DNA vaccine expressing HIV-1 gp120/immunoglobulin fusion protein enhances cellular immunity.

A. Ryo, K. Okuda, A. Kondo, 2010, Vaccine.

Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection

K. Ishii, H. Ikematsu, M. Mori, 2017, EBioMedicine.

Intracellular inflammatory sensors for foreign invaders and substances of self-origin.

F. Takeshita, N. Jounai, K. Kobiyama, 2012, Advances in experimental medicine and biology.

NLRP4 Negatively Regulates Autophagic Processes through an Association with Beclin1

K. Ishii, M. Shiina, K. Ogata, 2011, The Journal of Immunology.

The Atg5–Atg12 conjugate associates with innate antiviral immune responses

A. Miyawaki, K. Ishii, S. Akira, 2007, Proceedings of the National Academy of Sciences.

Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV

K. Hamajima, K. Xin, K. Okuda, 2003, The journal of gene medicine.

Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.

K. Okuda, K. Xin, S. Kawamoto, 2004, Vaccine.

Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine.

K. Ishii, K. Kabashima, F. Takeshita, 2016, Journal of dermatological science.

The non-canonical role of Atg family members as suppressors of innate antiviral immune signaling

A. Miyawaki, K. Okuda, F. Takeshita, 2008, Autophagy.

This information is current as DNA Vaccine Hampers Protective Potential of Flagellin Blocking of the TLR 5 Activation Domain

K. Ishii, S. Akira, S. Uematsu, 2007 .

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN

K. Ishii, T. Aoshi, N. Jounai, 2015, European journal of immunology.

Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination

K. Ishii, F. Takeshita, N. Jounai, 2012, Front. Cell. Inf. Microbio..

CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8+ T Cell Responses

K. Ishii, E. Moriishi, N. Jounai, 2017, The Journal of Immunology.

Detection of Progeny Immune Responses after Intravenous Administration of DNA Vaccine to Pregnant Mice

K. Hamajima, K. Xin, K. Okuda, 2001, Biological Procedures Online.

Oral administration of the adenovirus vector induces systemic immunity rather than intestinal mucosal immunity.

K. Xin, K. Okuda, N. Jounai, 2006, Vaccine.

Role of Extrachromosomal Histone H2B on Recognition of DNA Viruses and Cell Damage

K. Ishii, Tetsuhide Ito, Koichi Suzuki, 2013, Front. Genet..

Human immunodeficiency virus in Uzbekistan: epidemiological and genetic analyses.

N. Yuldasheva, M. Mizokami, Yasuhito Tanaka, 2003, AIDS research and human retroviruses.

Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation.

C. Coban, K. Ishii, N. Jounai, 2022, International immunology.

Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination

C. Coban, K. Ishii, T. Aoshi, 2013, Vaccines.

Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain

K. Ishii, Takashi Suzuki, Tokiko Watanabe, 2021, bioRxiv.